menu
    • menu

    Company profile for Akeso

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Akeso, Inc. (9926.HK), established in 2012, is a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide.Since our establishment, the Company has established a comprehensive in-house drug development platform (ACE Platform), encompassing fully integrated drug discovery and development functions, including ta...
    Akeso, Inc. (9926.HK), established in 2012, is a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide.Since our establishment, the Company has established a comprehensive in-house drug development platform (ACE Platform), encompassing fully integrated drug discovery and development functions, including target validation, antibody drug discovery and development, process development, and GMP-compliant commercial-scale manufacturing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AkesoChina Flag
    Country
    Country
    China
    Address
    Address
    No. 6, Shennong Road, Torch Development Zone, Zhongshan City, Guangdong Provin...
    Telephone
    Telephone
    0760-8987 3998
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.akesobio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/akeso-bio/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AkesoInc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ivonescimab + Chemo Shows Efficacy in TNBC at ESMO IO 2025
    Ivonescimab + Chemo Shows Efficacy in TNBC at ESMO IO 2025

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/updated-efficacy-data-of-ivonescimab-combined-with-chemotherapy-as-first-line-treatment-for-tnbc-presented-at-esmo-io-2025-302638641.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share
    China Approves Akeso's AB/BBB Bispecific for Alzheimer's Trials
    China Approves Akeso's AB/BBB Bispecific for Alzheimer's Trials

    17 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/akesos-bispecific-antibody-targeting-a-and-bbb-expressed-receptor-approved-for-alzheimers-disease-clinical-trials-in-china-302616507.html

    PR NEWSWIRE
    17 Nov 2025
    Share Share
    Akeso Initiates Phase I Trial For AK154 mRNA Vaccine
    Akeso Initiates Phase I Trial For AK154 mRNA Vaccine

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/akeso-announces-first-patient-dosed-in-phase-i-trial-of-personalized-mrna-vaccine-ak154-as-monotherapy-or-in-combination-with-cadonilimab-or-ivonescimab-for-adjuvant-treatment-of-pancreatic-cancer-302610059.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share
    Ivonescimab HARMONi-A Final OS Data Presented With HR=0.74
    Ivonescimab HARMONi-A Final OS Data Presented With HR=0.74

    07 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ivonescimab-harmoni-a-study-final-os-analysis-results-presented-at-sitc-2025-with-os-hr0-74--302608764.html

    PR NEWSWIRE
    07 Nov 2025
    Share Share
    Akeso Reveals (AK135) Preclinical Data Targeting IL-1RAP at SITC
    Akeso Reveals (AK135) Preclinical Data Targeting IL-1RAP at SITC

    07 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/akeso-unveils-promising-preclinical-data-for-il-1rap-targeting-antibody-ak135-at-sitc-2025-302608769.html

    PR NEWSWIRE
    07 Nov 2025
    Share Share
    HARMONi-A OS Data for Ivonescimab in EGFRm NSCLC at SITC 2025
    HARMONi-A OS Data for Ivonescimab in EGFRm NSCLC at SITC 2025

    31 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251031005548/en/Overall-Survival-Data-from-HARMONi-A-Featuring-Ivonescimab-in-Combination-with-Chemotherapy-vs.-Chemotherapy-in-2L-Treatment-of-Patients-with-EGFRm-NSCLC-in-China-to-be-Showcased-at-SITC-2025

    BUSINESSWIRE
    31 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search